Metropolis Healthcare
Metropolis Healthcare Limited, commonly referred to as Metropolis, is a leading diagnostic service provider headquartered in India. Established in 1980, the company has grown to become a prominent player in the healthcare industry, with a strong presence across major operational regions including Mumbai, Delhi, and Bengaluru. Specialising in pathology and diagnostic services, Metropolis offers a comprehensive range of tests, including advanced molecular diagnostics and preventive health check-ups. Their commitment to quality and innovation sets them apart, as they utilise state-of-the-art technology and adhere to stringent quality standards. With over four decades of experience, Metropolis has achieved significant milestones, including numerous accreditations and a vast network of laboratories and collection centres. This positions them as a trusted name in the healthcare sector, dedicated to enhancing patient care through accurate and timely diagnostics.
DitchCarbon Score
How does Metropolis Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Metropolis Healthcare's score of 27 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Metropolis Healthcare's reported carbon emissions
In 2024, Metropolis Healthcare reported total carbon emissions of approximately 44,218,000 kg CO2e from Scope 3, alongside 317,680 kg CO2e from Scope 1 and 6,825,350 kg CO2e from Scope 2. This data reflects a slight increase in Scope 3 emissions compared to 2023, where total emissions were about 44,000 kg CO2e for Scope 3, while Scope 1 and Scope 2 emissions remained consistent at 317,680 kg CO2e and 6,825,350 kg CO2e, respectively. In 2022, the company recorded total emissions of approximately 218,000 kg CO2e from Scope 3, with Scope 1 and Scope 2 emissions at 220,950 kg CO2e and 9,815,380 kg CO2e, respectively. This indicates a significant increase in Scope 2 emissions over the years, highlighting the company's growing operational footprint. Despite these figures, Metropolis Healthcare has not set specific reduction targets or climate pledges, nor are there any initiatives reported under the Science Based Targets initiative (SBTi). The absence of documented reduction targets suggests a need for enhanced climate commitments in line with industry standards. All emissions data is sourced directly from Metropolis Healthcare Limited, with no cascaded data from parent or related organizations. The company continues to operate within the healthcare sector, which is increasingly scrutinised for its environmental impact, underscoring the importance of transparent and actionable climate strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 220,950 | 000,000 | 000,000 |
| Scope 2 | 9,815,380 | 0,000,000 | 0,000,000 |
| Scope 3 | 218,000 | 00,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Metropolis Healthcare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
